Dean C.Bachus

Partner

Chicago + 1.312.269.4220

For more than a decade, Dean Bachus has focused his practice on executive compensation, benefits, and ERISA transactional matters. His experience covers tax planning and structuring compensation and benefit arrangements in domestic and international business acquisitions and dispositions. He also advises clients in connection with all compensation and employee benefit-related aspects of corporate transactions, reorganizations, financing arrangements, and public offerings, including negotiating, reviewing, and drafting transactional documents, supervising due diligence, and identifying issues arising under, and assisting in complying with, the Internal Revenue Code, ERISA, applicable labor laws, federal securities laws, and applicable exchange regulations.

Dean's practice includes designing, negotiating, and drafting equity-based compensation plans (including stock option, restricted stock, and phantom equity arrangements); cash bonus plans; employment, consulting, termination, severance, and change-in-control contracts; and restrictive covenant agreements, including noncompetition, nonsolicitation, and confidentiality arrangements.

Dean also advises clients on the structure, implementation, and administration of nonqualified employee compensation plans, programs, and arrangements, including the associated ERISA, federal tax, and securities implications. He also provides counsel to management teams and boards of directors on executive compensation and change-in-control arrangements in connection with corporate transactions and reorganizations and consults with shareholders, senior executives, and boards of directors on transactional strategies.

Dean has represented major private equity funds and publicly traded companies in hundreds of acquisitions and dispositions, focusing on benefit and compensation issues that arise in such transactions, as well as the design and maintenance of incentive programs and facilitating management turnover.

Experience

  • Riverside portfolio company UniFocus acquires KnowcrossJones Day advised The Riverside Company in the acquisition by portfolio company, UniFocus, of Knowcross, a global leader in task management and operational optimization software for the hospitality industry.
  • The Duchossois Group agrees to sell The Chamberlain Group LLC to BlackstoneJones Day is advising The Duchossois Group, Inc. in the sale of The Chamberlain Group LLC, a global leader in smart access solutions, to private equity funds managed by Blackstone.
  • Bridge to Life announces first close of $56 million growth financingJones Day advised Bridge to Life, Ltd. in its $56 million capital raise consisting of a secured credit facility and a Series A preferred equity investment.
  • Huntington Ingalls Industries acquires Alion Science and Technology for $1.65 billionJones Day advised Huntington Ingalls Industries in the $1.65 billion acquisition of Alion Science and Technology Corporation from Veritas Capital.
  • SER Capital Partners invests $82 million in Brightcore EnergyJones Day represented SER Capital Partners in its $82 million investment in Brightcore Energy, a clean energy and efficiency as a service company serving commercial, industrial, and institutional real estate owners.
  • Red Stone and its affiliates sell its business to Ready Capital CorporationJones Day represented Red Stone and its affiliates in the sale of its business to Ready Capital Corporation.
  • Misonix merges with BioventusJones Day represented Misonix, Inc. (Nasdaq: MSON) in its acquisition by Bioventus Inc. (Nasdaq: BVS).
  • Skyworks Solutions acquires Infrastructure and Automotive business of Silicon Laboratories for $2.75 billionJones Day advised Skyworks Solutions, Inc., an innovator of high-performance analog semiconductors, in connection with its acquisition of the Infrastructure and Automotive business of Silicon Laboratories Inc. (NASDAQ: SLAB), a leading provider of silicon, software, and solutions, in an all-cash asset transaction valued at $2.75 billion.
  • Delaware North sells Jumer’s Casino & Hotel to Bally's for $120 millionJones Day advised Delaware North, a global hospitality and entertainment company with operations in the sports, travel hospitality, restaurant and catering, lodging, gaming and specialty retail industries, in the sale of Jumer’s Casino & Hotel in Rock Island, Illinois, to Bally's Corporation for $120 million in cash.
  • Ansys Acquires Phoenix Integration, Inc.Jones Day advised Ansys, Inc. in its acquisition of Phoenix Integration, Inc., a provider of software that enables model-based engineering (MBE) and model-based systems engineering (MBSE) to customers across multiple industries, particularly in the aerospace and defense sectors.
  • Sumitovant Biopharma acquires remaining stake in Urovant SciencesJones Day advised Sumitovant Biopharma in its acquisition of all of the outstanding shares of Urovant Sciences Ltd. not already owned by Sumitovant at a price of $16.25 per share in cash.
  • PureCycle Technologies combines with Roth CH Acquisition I Co.Jones Day advised PureCycle Technologies LLC ("PureCycle") in its business combination with Roth CH Acquisition I Co. ("Roth SPAC"), a publicly-traded special purpose acquisition corporation backed by Roth Capital Partners and Craig-Hallum Capital Group, and Roth CH Acquisition I Co. Parent Corp., a wholly owned subsidiary of Roth CH ("Holdings"), among others.
  • Bentley Systems acquires E7Jones Day advised Bentley Systems, Incorporated on its acquisition of E7 Pty Ltd, a Brisbane, Australia-based leader in field-based construction delivery software for heavy civil construction.
  • Playboy becomes public company by combining with Mountain Crest Acquisition Corp.Jones Day advised Playboy Enterprises, Inc. in its business combination with Mountain Crest Acquisition Corp. (Nasdaq: MCAC) ("Mountain Crest"), a publicly-traded special purpose acquisition corporation (SPAC), whereby Playboy shareholders received shares of common stock in Mountain Crest, and Mountain Crest assumed outstanding Playboy debt, for a total purchase price valued at approximately $381 million.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.
  • Transtar Holding Company sold to Blue Point Capital PartnersJones Day advised Transtar Holding Company, a portfolio of industry-leading automotive aftermarket and original equipment businesses with a focus on high-quality products and unmatched customer service, in the sale of majority ownership to Blue Point Capital Partners.
  • Seal for Life acquires CanusaJones Day advised Arsenal Capital Partners in the acquisition by portfolio company, Seal For Life Industries, of the Canusa-CPS and Dhatec businesses from Shawcor.
  • Ansys acquires Analytical Graphics, Inc. for $700 millionJones Day advised Ansys, Inc. in the $700 million acquisition of Analytical Graphics, Inc., a provider of mission-driven simulation, modeling, testing and analysis software for aerospace, defense and intelligence applications.
  • Five9 acquires Inference Technologies GroupJones Day advised Five9, Inc. in its acquisition of Inference Technologies Group, Inc., a leading global provider of Intelligent Virtual Agents for sales and service organizations.
  • Astellas Pharma acquires iota BiosciencesJones Day advised Astellas Pharma Inc. in its acquisition of iota Biosciences.